Key facts
- Impulse Dynamics’s last known valuation is $127.0M (Jan 2000).
- It has raised $930.8M; the latest was Later Stage VC ($242.1M) in Dec 2025.
- Notable investors include Wellington Management, Sands Capital, Perceptive Advisors, Redmile Group, Squarepoint Capital — 22 tracked in total.
- Status: Acquired/Merged (Operating Subsidiary).
- ·The complete investor list — 22 names
- ·Watchlist + deal alerts for Impulse Dynamics
- ·The full record, as it builds
Funding rounds
No funding rounds for Impulse Dynamics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Impulse Dynamics
Developer of a cardiac contractility modulation technology designed to treat chronic heart failure problems. The company's technology delivers non-excitatory electric pulses to the heart muscles with the potential of enhancing cardiac strength, initiating multiple biochemical and neurohormonal changes to the myocardium that are determined to improve the lives of heart failure patients, enabling doctors to reduce the risk of heart attacks and maintain cardiac health.
- Sector
- Healthcare
- HQ
- Marlton, NJ, United States
- Founded
- 1997
- Employees
- 265
- Website
- impulse-dynamics.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Impulse Dynamics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Impulse Dynamics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Impulse Dynamics in its N-PORT filings yet. We sweep new filings monthly.